AuraGlow: GHK-Cu (50mg)
For research use only. Not for human consumption. Not a TGA-registered therapeutic good. AuraGlow features GHK-Cu (Glycine-Histidine-Lysine Copper) — a naturally occurring copper-binding tripeptide that has been the subject of extensive preclinical investigation into skin biology, wound repair, antioxidant activity, and cellular remodelling. First isolated from human plasma albumin, GHK-Cu has been studied across a broad range of in vitro and in vivo models over four decades of published research. Compound Profile GHK-Cu — Copper-Binding Tripeptide: Preclinical research reports involvement in collagen and glycosaminoglycan synthesis, MMP activity modulation, antioxidant enzyme upregulation (superoxide dismutase, catalase), and activation of wound healing gene cascades. In vitro studies demonstrate fibroblast proliferation, keratinocyte migration, and upregulation of tissue remodelling genes. Animal models report effects on wound closure rates, skin thickness, and angiogenesis at dermal injury sites. Contents Component Size Purity GHK-Cu 50mg 99%+ HPLC Lyophilised powder, HPLC verified. Certificate of Analysis available on request. Reconstitution Guidelines Reconstitute with bacteriostatic water. Recommended: 1-5mg/ml depending on application volume. Use our Peptide Reconstitution Calculator Storage Lyophilised: 2-8°C, protected from light | Reconstituted: 2-8°C, use within 28 days | Long-term: -20°C Verify Our Beligas Authorisation AU Supplement Co is an authorised Beligas reseller. Verify at beligas.org/verify-distributors. For research use only. Not for human consumption. Not a TGA-registered therapeutic good.
Specifications
- Quantity
- 1 Vial, 2 Vials
AI Readiness
Good foundation, but some important product data is still missing.